NCT06058078View on ClinicalTrials.gov

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Lupus Nephritis
Interventions
DRUG

RY_SW01 cell injection

Injected RY\_SW01 allogonic umbilical cord-derived mesenchymal stem cells(UCMSCs)

DRUG

Basic treatment

Drugs for LN treatment

Trial Locations (1)

210008

RECRUITING

the Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Jiangsu Renocell Biotech Company

INDUSTRY